Vaccine Breakthrough Infections with SARS-CoV-2 Variants
View abstract on PubMed
Summary
This summary is machine-generated.Fully vaccinated individuals can still contract SARS-CoV-2 variants. This study found breakthrough infections in two women despite vaccination, highlighting the need for ongoing variant surveillance.
Area Of Science
- Virology
- Immunology
- Epidemiology
Background
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants pose a significant public health challenge.
- Vaccination is a primary strategy to prevent coronavirus disease 2019 (COVID-19).
Observation
- Two women in a cohort of 417 individuals experienced vaccine breakthrough infections.
- Both women had received two doses of either BNT162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna) vaccine at least two weeks prior.
Findings
- Despite vaccine efficacy, both women developed COVID-19 symptoms and tested positive for SARS-CoV-2.
- Viral sequencing identified concerning variants, including E484K in one case and T95I, del142-144, and D614G mutations in both.
Implications
- Vaccinated individuals remain at potential risk of infection with SARS-CoV-2 variants.
- Continued efforts are crucial for infection prevention, diagnosis, and characterization of variants in vaccinated populations.
Related Concept Videos
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Viral Recombination Can Create New Diseases
Some diseases can infect multiple species. For example, pigs can be infected by some human and...
Overview
Vaccination is the administration of antigenic material from pathogens to confer immunity against a specific microorganism. Vaccination primes the immune system to recognize and mount an immune response faster and more effectively if the real pathogen is encountered. Vaccinations are one of the most efficient ways to protect both individual humans and the general public from disease. A growing anti-vaccination skepticism risks the successes of vaccination programs that helped reduce...
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Overview
The ability of a single antibody to recognize multiple structurally similar epitopes is an important immune defense strategy that enables the host to efficiently defend against many potentially threatening pathogens. However, cross-reactivity also elicits allergy symptoms against related allergens. It is increasingly important to understand the principles of cross-reactivity, as antibodies are actively being developed as therapeutic modalities for diverse diseases, including cancer.
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

